Raben David bought BCAX
November 25, 2025 · Form 4 insider transaction
Raben David bought 906 shares of Bicara Therapeutics Inc. at $3.79 per share, a transaction worth $3.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
906
Price
$3.79
Total value
$3.4K
InsiderRaben David
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 25, 2025
Filing dateNovember 25, 2025
Shares owned after36,403
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.